Bristol-Myers Squibb Company (BMY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$128.37B
EV to revenue ratio (TTM)
3.18
EV to ebitda
10.10
Financial Performance
Revenue (TTM)
$50.03B
Gross profit (TTM)
$35.28B
EBITDA
$18.24B
Profitability
Operating margin (TTM)
33.80%
Profit margin
18.50%
Return on assets (TTM)
10.90%
Return on equity (TTM)
44.00%
Per Share Metrics
Revenue per share (TTM)
$24.54
EPS
$4.51
Diluted EPS (TTM)
$4.51
Book value
$11.45
Dividend per share
$2.52
Dividend yield
4.06%
Valuation Multiples
P/E ratio
13.92
Trailing P/E
13.92
Forward P/E
9.37
PEG ratio
17.04
Price to sales ratio (TTM)
2.57
Price to book ratio (TTM)
5.43
Growth
Quarterly earnings growth (YoY)
6.90%
Quarterly revenue growth (YoY)
-2.80%
Analyst Sentiment
Strong buy
4
Buy
6
Hold
17
Sell
1
Strong sell
0
Risk & Volatility
Beta
0.19